23 January 2014

Aspen to add 42 new jobs in Ireland

Dublin - 23 January 2014 - Aspen, a global pharmaceutical company, is to expand its Irish operation by adding 42 new jobs. The new jobs will bring Aspen’s total workforce in Ireland to 100 within the next 12 months. The announcement is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland. 

Making the announcement, Minister for Jobs, Enterprise and Innovation, Richard Bruton TD said “Pharma is a key sector we have targeted in our Action Plan for Jobs. In particular we have targeted generics and biopharma companies who continue to grow despite difficulties in the traditional pharma sector, and in the past two years employment has grown in the sector overall. Today’s announcement that Aspen, a major global pharma company in, is adding over 40 jobs in Dublin is very welcome and represents a further boost for the sector in Ireland”. 

The company first established an operation in Ireland in 2010. In addition the company established a global regulatory, pharmacovigilance, quality assurance and supply projects centre of excellence in Citywest in 2012.

Stephen Saad, Group Chief Executive of Aspen said, ‘‘I am delighted to see the continued growth of Aspen here in Ireland. Ireland’s strong pharmaceutical sector provides a workforce with the specialised skills we require and a strong regulatory and business environment. I would like to thank the Irish Government and IDA Ireland for their support and look forward to the future development of Aspen in Ireland.’’ 

Commenting on the announcement, Barry O’Leary, CEO of IDA Ireland said, ‘“Pharmaceuticals is a major strategic sector for Ireland, with nine out of the top ten global companies located here. As Aspen continues to grow globally through a series of acquisitions and partnerships, the Irish operation is well placed within the group to increase its footprint in Europe. I look forward to continue to work closely with Aspen as it further embeds its operations here

Aspen is a supplier of branded and generic pharmaceuticals in more than 150 countries across the world and of consumer and nutritional products in selected territories. Aspen is a leading generics manufacturer in the Southern hemisphere and is Africa’s largest pharmaceutical manufacturer. Aspen is ranked as the ninth largest generic company in the world. The Group has 22 manufacturing facilities at 16 sites on 6 continents and approximately 8200 employees. Aspen is listed on the Johannesburg Stock Exchange and is included in its Top 40 Index. 

Source: IDA Ireland